Celularity CFO Joseph DosSantos departs; John Sprague named acting CFO

Celularity Inc

Joseph DosSantos left as SVP Finance and Acting CFO on Feb 27, 2026 for personal reasons.
John Sprague appointed Acting CFO effective same date.
No additional details on compensation or transition timeline provided.

item 5.02

Source: SEC EDGAR

accession 0001493152-26-009017

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.